Est. January 15, 2019


Pvt. Ltd.
SkelRegen is a life technology start-up with unique therapeutic technology for society in the field of bone tissue engineering. Currently developing biological maxillofacial bone implants which can completely reconstruct the commuted bone defects.

Founding Members

Shibu Chameettachal
Pursuing PhD
15 years
Dr N. Vijay Kumar
Co-founder & Director COO
Pursuing PhD
Dr Subha Narayan Rath
PhD in Bioengineering
5 years

Team Members

  • 3 Co-Founders
  • 2 Developers
  • 1 Business developer

Target Market

  • Dental clinics
  • Oral cancer clinics
  • Maxillofacial implant industry
  • People with facial bone defects


  • Horizontal: Healthcare
  • Vertical: 3D Printing, Biomedical science

Problem Statement

SkelRegen is trying to fulfill the huge demand for biomaterial supporting natural bone growth with self-degradation property to avoid multiple surgeries and adequate mechanical strength.

Value Proposition

SkelRegen developed a Biomaterial for bone defect implants that will degrade and form the natural bone. The implants are patient-specific which are developed using the 3D printing technique.

Current Stage

  • Prototype

Type of Business

  • Product-based

Products / Services

Development of biological maxillofacial bone customized implants that can completely reconstruct the commuted bone defects using 3D printing.

Key Highlights

  • One patent granted
  • Received BIRAC-BIG grant in 2019
  • Received CSR funding from HDFC bank.

Disclaimer: The information shared in the document is provided by the startup. iTIC shall not be held responsible for the information shared by the startup.